AGN.AX
Price:
$0.25
Market Cap:
$32.11M
Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate use to protect brain cells and reduce cell death during a stroke and other types of neural injuries. The company was incorporated in 2019 and is based in Nedlands, Australia.
Industry
Biotechnology
IPO Date
2021-06-11
Stock Exchange
ASX
Ticker
AGN.AX
According to Argenica Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 21.56M. This represents a change of -66.75% compared to the average of 64.85M of the last 4 quarters.
The mean historical Enterprise Value of Argenica Therapeutics Limited over the last ten years is 36.85M. The current 21.56M Enterprise Value has changed 5.75% with respect to the historical average. Over the past ten years (40 quarters), AGN.AX's Enterprise Value was at its highest in in the June 2025 quarter at 87.30M. The Enterprise Value was at its lowest in in the December 2019 quarter at 0.
Average
36.85M
Median
23.21M
Minimum
7.49M
Maximum
86.37M
Discovering the peaks and valleys of Argenica Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 205.38%
Maximum Annual Enterprise Value = 86.37M
Minimum Annual Increase = -59.91%
Minimum Annual Enterprise Value = 7.49M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 86.37M | 38.98% |
| 2024 | 62.14M | 163.85% |
| 2023 | 23.55M | 2.97% |
| 2022 | 22.87M | 205.38% |
| 2021 | 7.49M | -59.91% |
The current Enterprise Value of Argenica Therapeutics Limited (AGN.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
57.35M
5-year avg
40.49M
10-year avg
36.85M
Argenica Therapeutics Limited’s Enterprise Value is less than Noxopharm Limited (29.86M), less than Prescient Therapeutics Limited (82.47M), less than BCAL Diagnostics Limited (34.64M), less than Microba Life Sciences Limited (25.07M), less than INOVIQ Ltd (32.64M), less than Nova Eye Medical Limited (37.84M), less than AnteoTech Limited (45.99M), less than Emyria Limited (29.77M), greater than Immuron Limited (14.62M), greater than Tissue Repair Ltd (7.63M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 29.86M | $28.93M | |
| 82.47M | $89.38M | |
| 34.64M | $36.78M | |
| 25.07M | $33.58M | |
| 32.64M | $38.79M | |
| 37.84M | $39.87M | |
| 45.99M | $46.37M | |
| 29.77M | $32.73M | |
| 14.62M | $17.33M | |
| 7.63M | $19.95M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Argenica Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Argenica Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Argenica Therapeutics Limited's Enterprise Value?
What is the highest Enterprise Value for Argenica Therapeutics Limited (AGN.AX)?
What is the 3-year average Enterprise Value for Argenica Therapeutics Limited (AGN.AX)?
What is the 5-year average Enterprise Value for Argenica Therapeutics Limited (AGN.AX)?
How does the current Enterprise Value for Argenica Therapeutics Limited (AGN.AX) compare to its historical average?